Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,144.30 | 17.40 | 0.21% |
| CAC 40 | 7,876.36 | 85.65 | 1.10% |
| DAX 40 | 22,539.98 | 376.49 | 1.70% |
| Dow JONES (US) | 41,989.96 | 11.80 | -0.03% |
| FTSE 100 | 8,634.80 | 51.99 | 0.61% |
| HKSE | 23,206.84 | 87.26 | 0.38% |
| NASDAQ | 17,449.89 | 150.60 | 0.87% |
| Nikkei 225 | 35,512.57 | 111.91 | -0.31% |
| NZX 50 Index | 12,368.78 | 56.18 | 0.46% |
| S&P 500 | 5,633.07 | 21.22 | 0.38% |
| S&P/ASX 200 | 7,943.10 | 17.90 | 0.23% |
| SSE Composite Index | 3,348.44 | 12.69 | 0.38% |